Endeavour Silver Corp. (EXK) Reaches $2.63 After 4.00% Up Move; Akebia Therapeutics (AKBA)’s Sentiment Is 2.23

January 14, 2018 - By Adrian Mccoy

The stock of Endeavour Silver Corp. (NYSE:EXK) is a huge mover today! The stock increased 5.20% or $0.13 during the last trading session, reaching $2.63. About 1.61M shares traded or 7.07% up from the average. Endeavour Silver Corp. (NYSE:EXK) has declined 7.14% since January 14, 2017 and is downtrending. It has underperformed by 23.84% the S&P500.The move comes after 9 months positive chart setup for the $328.62M company. It was reported on Jan, 14 by Barchart.com. We have $2.74 PT which if reached, will make NYSE:EXK worth $13.14 million more.

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor biology. The company has market cap of $741.18 million. The Company’s lead product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. It currently has negative earnings. The firm is also developing a HIF portfolio of product candidates that include AKB-6899 for the treatment of anemia; and AKB-5169, a preclinical compound for the treatment for inflammatory bowel disease.

Analysts await Akebia Therapeutics, Inc. (NASDAQ:AKBA) to report earnings on March, 5. They expect $-0.18 earnings per share, up 81.82% or $0.81 from last year’s $-0.99 per share. After $-0.49 actual earnings per share reported by Akebia Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -63.27% EPS growth.

Since January 1, 0001, it had 0 insider purchases, and 5 sales for $377,477 activity.

Dafna Capital Management Llc holds 1.66% of its portfolio in Akebia Therapeutics, Inc. for 135,738 shares. Nantahala Capital Management Llc owns 1.37 million shares or 1.32% of their US portfolio. Moreover, Perceptive Advisors Llc has 1.22% invested in the company for 1.63 million shares. The California-based Eam Investors Llc has invested 0.62% in the stock. Opus Point Partners Management Llc, a New York-based fund reported 21,009 shares.

The stock increased 0.64% or $0.1 during the last trading session, reaching $15.68. About 181,973 shares traded. Akebia Therapeutics, Inc. (AKBA) has risen 76.80% since January 14, 2017 and is uptrending. It has outperformed by 60.10% the S&P500.

Ratings analysis reveals 100% of Akebia Therapeutics’s analysts are positive. Out of 3 Wall Street analysts rating Akebia Therapeutics, 3 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. AKBA was included in 3 notes of analysts from September 29, 2016. As per Thursday, September 29, the company rating was initiated by Brean Capital. The stock of Akebia Therapeutics, Inc. (NASDAQ:AKBA) earned “Buy” rating by Aegis Capital on Tuesday, November 15. The rating was maintained by H.C. Wainwright on Tuesday, December 27 with “Buy”.

Endeavour Silver Corp., a mid-tier precious metals mining company, engages in evaluation, acquisition, exploration, development, extraction, processing, refining, and reclamation of silver mining properties in Mexico and Chile. The company has market cap of $328.62 million. The firm also explores for gold deposits. It has a 526 P/E ratio. It holds interest in the Guanaceví mine in the Durango state; and the Bolañitos and El Cubo mines in the Guanajuato state of Mexico.

Among 8 analysts covering Endeavour Silver Corp (NYSE:EXK), 3 have Buy rating, 1 Sell and 4 Hold. Therefore 38% are positive. Endeavour Silver Corp had 27 analyst reports since August 24, 2015 according to SRatingsIntel. H.C. Wainwright maintained Endeavour Silver Corp. (NYSE:EXK) rating on Friday, April 7. H.C. Wainwright has “Buy” rating and $6 target. On Friday, February 17 the stock rating was initiated by Noble Financial with “Buy”. As per Friday, August 4, the company rating was maintained by Noble Financial. The stock of Endeavour Silver Corp. (NYSE:EXK) has “Buy” rating given on Thursday, January 11 by H.C. Wainwright. On Monday, March 7 the stock rating was upgraded by TD Securities to “Hold”. H.C. Wainwright maintained the stock with “Buy” rating in Thursday, November 16 report. The stock of Endeavour Silver Corp. (NYSE:EXK) earned “Market Perform” rating by BMO Capital Markets on Tuesday, April 4. H.C. Wainwright maintained the stock with “Buy” rating in Thursday, August 31 report. Zacks upgraded Endeavour Silver Corp. (NYSE:EXK) on Monday, August 24 to “Sell” rating. Noble Financial maintained Endeavour Silver Corp. (NYSE:EXK) on Wednesday, October 11 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News